Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Natera Inc (NTRA)

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,195,926
  • Shares Outstanding, K 96,957
  • Annual Sales, $ 625,490 K
  • Annual Income, $ -471,720 K
  • 60-Month Beta 1.33
  • Price/Sales 8.57
  • Price/Cash Flow N/A
  • Price/Book 11.98
Trade NTRA with:

Options Overview Details

View History
  • Implied Volatility 64.24% ( -6.13%)
  • Historical Volatility 58.71%
  • IV Percentile 40%
  • IV Rank 23.01%
  • IV High 137.66% on 03/09/22
  • IV Low 42.29% on 11/05/21
  • Put/Call Vol Ratio 1.32
  • Today's Volume 51
  • Volume Avg (30-Day) 618
  • Put/Call OI Ratio 1.99
  • Today's Open Interest 13,590
  • Open Int (30-Day) 11,882

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.42
  • Number of Estimates 5
  • High Estimate -1.34
  • Low Estimate -1.48
  • Prior Year -1.63
  • Growth Rate Est. (year over year) +12.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.46 +51.32%
on 07/13/22
57.88 -4.68%
on 08/11/22
+16.72 (+43.49%)
since 07/12/22
3-Month
29.21 +88.87%
on 05/13/22
57.88 -4.68%
on 08/11/22
+26.26 (+90.83%)
since 05/12/22
52-Week
26.10 +111.38%
on 03/09/22
129.09 -57.26%
on 09/23/21
-46.92 (-45.96%)
since 08/12/21

Most Recent Stories

More News
Natera Announces Enrollment Completion for RenaCARE Study

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced full enrollment for the RenaCARE (Renasight Clinical...

NTRA : 55.17 (+2.95%)
Natera Announces Q-Sub Filing with FDA for its Panorama® NIPT

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, announced earlier today at the Canaccord Genuity 42nd Annual Growth...

NTRA : 55.17 (+2.95%)
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -2.04% and 2.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 55.17 (+2.95%)
GDRX : 7.36 (-3.16%)
Wall Street Analysts Predict a 47% Upside in Natera (NTRA): Here's What You Should Know

The consensus price target hints at a 47.5% upside potential for Natera (NTRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions...

NTRA : 55.17 (+2.95%)
Natera Announces Second Quarter 2022 Earnings Conference Call

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter...

NTRA : 55.17 (+2.95%)
Earnings Preview: DermTech, Inc. (DMTK) Q2 Earnings Expected to Decline

DermTech, Inc. (DMTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DMTK : 6.80 (+8.45%)
NTRA : 55.17 (+2.95%)
Bull of the Day: Illumina (ILMN)

Leader in genomic sequencing still growing sales over 15% as lifescience labs crunch more genetic data

ILMN : 208.32 (-8.40%)
NTRA : 55.17 (+2.95%)
Federal Circuit Rules in Favor of Natera, Upholding Invalidation of CareDx Patents

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced that the Federal Circuit Court of...

NTRA : 55.17 (+2.95%)
Does Natera (NTRA) Have the Potential to Rally 76% as Wall Street Analysts Expect?

The consensus price target hints at a 75.6% upside potential for Natera (NTRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions...

NTRA : 55.17 (+2.95%)
Medicare Extends Coverage of Natera's Signatera™ MRD Test to Muscle Invasive Bladder Cancer

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it has received written confirmation from the CMS...

NTRA : 55.17 (+2.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 59.53
2nd Resistance Point 57.98
1st Resistance Point 56.58
Last Price 55.17
1st Support Level 53.63
2nd Support Level 52.08
3rd Support Level 50.68

See More

52-Week High 129.09
Fibonacci 61.8% 89.75
Fibonacci 50% 77.60
Fibonacci 38.2% 65.44
Last Price 55.17
52-Week Low 26.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar